The functional activity of XAGE-2 is enhanced by various chemical activators that operate through distinct signaling pathways, ensuring precise regulation and response within cellular environments. One class of these activators functions by modulating the levels of cyclic adenosine monophosphate (cAMP) within the cell. By either directly stimulating adenylyl cyclase or inhibiting the degradation of cAMP by phosphodiesterases, these activators ensure a sustained and elevated concentration of cAMP, a crucial secondary messenger. The increase in cAMP levels leads to the activation of protein kinase A (PKA), which then phosphorylates target proteins, resulting in a cascade of signaling events that ultimately enhance the activity of XAGE-2. Additionally, the introduction of cAMP analogs resistant to degradation acts in a similar manner to bolster cellular PKA activity, further amplifying the signaling that converges on the activation of XAGE-2.
Complementary to cAMP-mediated mechanisms, the intracellular concentration of calcium ions also plays a pivotal role in the activation of XAGE-2. Certain activators, functioning as ionophores, facilitate the influx of calcium into the cytoplasm, thereby elevating intracellular calcium levels and triggering calcium-dependent protein kinases. These kinases are instrumental in transducing signals that lead to the activation of XAGE-2. Moreover, the generation of nitric oxide and subsequent activation of guanylyl cyclase culminates in increased levels of cyclic guanosine monophosphate (cGMP). The rise in cGMP levels, much like cAMP, activates a specific set of protein kinases that contribute to the regulatory control of XAGE-2 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, raising cAMP levels which can enhance the activity of XAGE-2 through PKA-mediated signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A synthetic catecholamine and beta-adrenergic agonist that increases intracellular cAMP, promoting XAGE-2 activation via the beta-adrenergic signaling cascade. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
A non-selective inhibitor of phosphodiesterases which prevents cAMP degradation, potentially increasing XAGE-2 activity through elevated cAMP signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
PGE2 activates G protein-coupled EP receptors leading to increased intracellular cAMP, which in turn could enhance XAGE-2 activity mediated by PKA phosphorylation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
A cAMP analog resistant to degradation by phosphodiesterases, which can activate PKA and thereby increase XAGE-2 activity through cAMP-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Ionophore that increases intracellular calcium concentration, indirectly activating calcium-dependent signaling pathways that may upregulate XAGE-2 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activator of protein kinase C (PKC) which may promote XAGE-2 activation via PKC-dependent signaling pathways. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
A calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent protein kinases which could enhance XAGE-2 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cell-permeable cAMP analog that activates PKA, potentially increasing XAGE-2 activity through cAMP-PKA mediated signaling mechanisms. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
A selective phosphodiesterase-4 inhibitor that prevents cAMP breakdown, which could result in increased XAGE-2 activity through enhanced cAMP signaling. | ||||||